Patrys secures ethics approval for Phase 1A clinical trial on delirium candidate
Patrys has received HREC approval to commence its Phase 1A clinical trial of RLS-2202 for the treatment of delirium in acute care settings.
Market Cap $53.12M
!
Reach your audience today.

Corporate Spotlight
Last update - 10.10am 28/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 1.8¢ | Day High | 1.8¢ | Day Low | 1.8¢ | |||
| Daily Volume | 3627189 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 1.8¢ | 2668138 | 0 | 1.9¢ | 5419505 | |
Directors & Senior Management
| Mr. Todd Jeffrey Hibberd | Chief Executive Officer, Managing Director, Executive Director |
Data source: ADVFN